• Overview
• Adnectin Product Class
• PROfusion Discovery Engine
• Patent Estate

Overview

Adnexus is a leader in the discovery and development of Adnectins™, a novel, proprietary class of targeted biologics. Adnectins are proteins that can be designed toward a broad range of targets. Given their simple structure, Adnectins are relatively straight forward to develop and produce, creating significant opportunity to rapidly advance differentiated products across many therapeutic areas. We believe these, and other important features of Adnectins, as well as our highly efficient proprietary processes for discovering and developing them (PROfusion™), potentially offer important advantages over traditional antibody and small molecule approaches for some targets.

We create Adnectins using our proprietary protein engineering system called PROfusion. This technology enables us to easily engineer and test trillions of Adnectins against a target of interest to identify those Adnectins that will offer the most desirable drug properties. PROfusion represents a significant improvement in discovery productivity by minimizing the time to identify high-quality product candidates.

We believe the combination of our novel Adnectin class of molecules and powerful PROfusion discovery system creates an opportunity to rapidly generate highly differentiated medicines.

Click below to learn more about Adnectins and about PROfusion:

• Adnectins
• PROfusion